Show
Sort by
-
- Conference Paper
- C3
- open access
Chemogenetic seizure suppression in a mouse model for temporal lobe epilepsy : 'pumping up the jam'?
-
- PhD Thesis
- open access
Preclinical evaluation of chemogenetics as a new treatment for drug-resistant epilepsy
(2022) -
Chemogenetic seizure control with clozapine and the novel ligand JHU37160 outperforms the effects of Levetiracetam in the intrahippocampal kainic acid mouse model
-
Long‐term chemogenetic suppression of seizures in a multifocal rat model of temporal lobe epilepsy
-
- Journal Article
- A1
- open access
Level of hM4D(Gi) DREADD expression determines inhibitory and neurotoxic effects in the hippocampus
-
- PhD Thesis
- open access
Chemogenetic neuromodulation in a rat model of epilepsy
(2021) -
- Conference Paper
- C3
- open access
Long-term effect of chemogenetic suppression of excitatory hippocampal neurons on spontaneous seizures in a rat model for temporal lobe epilepsy
-
- Conference Paper
- C3
- open access
Chemogenetic suppression of spontaneous seizures in a rat model for temporal lobe epilepsy
-
Long-term chemogenetic suppression of spontaneous seizures in a mouse model for temporal lobe epilepsy.
-
- Conference Paper
- C3
- open access
Chemogenetic therapy strongly suppresses hippocampal excitability and spontaneous seizures in a rat model for temporal lobe epilepsy